Dyne Therapeutics

Dyne Therapeutics is a clinical-stage muscle disease company dedicated to developing innovative, life-transforming therapies for people living with genetically driven diseases. They utilize their proprietary FORCE™ platform to overcome limitations in muscle tissue delivery, allowing them to advance modern oligonucleotide therapeutic candidates. Their primary focus is on myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral muscular dystrophy (FSHD), all of which have significant impacts on affected communities worldwide.

Dyne is committed to listening to and learning from the communities they serve, believing that their stories and insights are crucial to developing truly transformative therapies. This commitment manifests in their robust community engagement initiatives, including patient advisory boards, community conversations, and educational webinars. Their commitment to corporate responsibility also extends to their employees, creating a differentiated culture that fosters a sense of belonging, empowers individual growth, and encourages diversity of perspectives.

Dyne Therapeutics offers a flexible work environment with a comprehensive benefits package that includes paid time off, including flexible vacation, and one-week year-end office closure. They also provide on-site gym and personal training and lunch delivered onsite daily. Dyne is committed to employee health and well-being, offering a competitive and comprehensive benefits package that fosters work-life balance.

Dyne Therapeutics offers a comprehensive benefits package to support the health and well-being of its employees and their families. These benefits include medical, dental, and vision insurance plans with 100% premiums covered by the company, short- and long-term disability, life insurance, health reimbursement accounts covering 100% of medical deductible expenses, flexible and dependent care spending accounts, an employee assistance program, a 401(k) plan with company match, equity options and restricted stock units, an on-site gym and personal training, paid holidays, flexible paid time off, paid family and parental leave, daily onsite lunch delivery, shuttle commuter benefits, and free on-site parking.

Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative, life-transforming therapeutics for people living with genetically driven diseases. Their mission is to overcome the limitations of muscle tissue delivery to stop or reverse disease progression for patients with myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral muscular dystrophy (FSHD). They are utilizing their proprietary FORCE™ platform to develop targeted, modern oligonucleotide therapeutics.

Dyne Therapeutics fosters a collaborative and purpose-driven culture centered around a commitment to delivering life-transforming therapies for people with serious muscle diseases. They value inclusion, transparency, respect, honesty, and unity, encouraging fearless innovation and bold ideas from their employees, known as "Dynamos." The company prioritizes employee engagement through initiatives like regular company meetings, development discussions, and volunteer opportunities, creating a supportive and dynamic work environment.

Dyne Therapeutics prioritizes creating an inclusive environment that values diverse perspectives, backgrounds, and approaches to developing innovative therapies. Their efforts are rooted in a commitment to attracting, retaining, and developing employees through equitable recruitment practices, comprehensive onboarding, and professional development opportunities. They also foster a differentiated culture based on their core values, including "Dyne Family," which emphasizes acting with inclusion, transparency, respect, honesty, and unity.